Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6479 USD | +0.36% | -2.37% | -13.10% |
05-07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
04-04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.10% | 13.61M | |
+28.54% | 48.16B | |
-1.09% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.14% | 25.59B | |
-22.80% | 18.96B | |
+8.26% | 12.92B | |
+28.76% | 12.03B | |
-1.89% | 11.77B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Onconova Therapeutics : Guggenheim Starts Onconova Therapeutics at Buy With $4 Price Target